Amir Iravani
@DrAIravani
Followers
677
Following
2K
Statuses
359
Theranostics and Molecular Imaging, #prostatecancer, #NET, @FredHutch. @UW
WA, USA
Joined January 2020
Great results and congratulations to everyone involved! First randomized trial of PSMA theranostics and unlike industry-sponsored trials against an active arm. @DrMHofman @drlouiseemmett @PeterMacCC @ANZUPtrials @pros_tic @WUSTLmed @MIRimaging
3
15
52
RT @DrMHofman: SPECT deserves RESPECT! @drlouiseemmett makes the argument that it is a powerful tool for theranostics ➤ enabling early,…
0
26
0
RT @CalaisJeremie: Low- and High-Volume Disease in mHSPC: from CHAARTED to #PSMA PET #stagemigration
@UnterrainerL…
0
26
0
RT @thomashopemd: We are excited to host the second PSMA PET conference with @UCLATheranostic and the @PCF_Science in March. The abstract d…
0
10
0
We are recruiting! Learn everything about #Theranostics at leading organization with an excellent team! @UWRadiology @Fred
Apply now to join our #UWRadiology team as a #Theranostics Fellow! This new program is offered in the @fredhutch environment and we’re accepting applications for 2025 and beyond. #UWMedicine @DrAIravani
0
1
17
RT @JournalofNucMed: Total tumor volume and new lesions on LuPSMA SPECT/CT are independent prognostic imaging biomarkers and should be used…
0
8
0
RT @DrMHofman: Longer follow-up from our landmark ProPSMA study just out @EurUrolOncol: PSMA nodal status is prognostic! At 3 years 70% of…
0
49
0
Moving toward precision response assessment and dynamic risk startification by SPECT/CT in mCRPC receiving LuPSMA! #PSMA #Theranostics @fredhutch @UW @drlouiseemmett @DrMHofman @thomashopemd
0
14
52
RT @urotoday: Patient selection for radioligand therapy: Case study discussion. @DrAIravani & Evan Yu, MD @fredhutch join @PhillipKooMD @Ba…
0
3
0
RT @PSMAconference: Registration is open for the 2025 PSMA & Beyond Conference! Join us in LA on March 28-29! Register now at: https://t.co…
0
4
0
RT @CzerninJohannes: SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu…
0
8
0
RT @uwmnewsroom: PHOTO: David Baker @UWBiochemistry @UWproteindesign @uwmedicine taking via computer at his Seattle home early this morning…
0
46
0
RT @urotoday: Patient selection for radioligand therapy: Case study discussion. @DrAIravani & Evan Yu, MD @fredhutch join @PhillipKooMD @Ba…
0
3
0
RT @UWRadiology: (1/2) #UWRadiology was thrilled to co-host the 2024 Molecular Imaging Symposium this weekend, along with @fredhutch and @U…
0
3
0
RT @BitalSavirBMD: It was an honor to collaborate with my colleagues Dr. @DrAIravani @Cpaller @CarlosUribeM, and Melissa Craig at the 2024…
0
2
0
RT @DrMHofman: In-transit back from #ESMO24 reflecting on my last attendance #ESMO17 where I had the pleasure to present our first 30 patie…
0
28
0
RT @urotoday: Patient selection for radioligand therapy: Case study discussion. @DrAIravani & Evan Yu, MD @fredhutch join @PhillipKooMD @Ba…
0
2
0
RT @DrMHofman: A real honour to deliver the Saul Hertz lecture @SNM_MI #snmmi24 Key features of Dr Saul Hertz’s success: compassionate car…
0
15
0